Skip to main content
NASDAQ:CLVS

Clovis Oncology SEC Filings & 10K Form

$5.87
+0.25 (+4.45 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.68
$6.00
50-Day Range
$5.29
$7.05
52-Week Range
$4.08
$11.10
Volume3.20 million shs
Average Volume10.77 million shs
Market Capitalization$613.80 million
P/E RatioN/A
Dividend YieldN/A
Beta2.1

SEC Filings

Clovis Oncology (NASDAQ:CLVS) SEC Filings

DateFilerForm TypeView
05/09/2021
11:15 PM
Clovis Oncology (Filer)
Form EFFECT
05/05/2021
3:22 PM
Clovis Oncology (Filer)
Form S-3/A
05/05/2021
11:46 AM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2021
7:05 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
8:43 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
8:40 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
8:40 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
8:39 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
8:39 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
3:21 PM
Clovis Oncology (Filer)
Form DEFA14A
04/28/2021
3:16 PM
Clovis Oncology (Filer)
Form DEF 14A
04/16/2021
3:05 PM
Clovis Oncology (Filer)
Form PRE 14A
04/12/2021
10:52 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
03/29/2021
3:33 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 3/A
03/03/2021
5:46 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:42 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:41 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:40 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:39 PM
Clovis Oncology (Issuer)
MAHAFFY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:35 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
7:55 AM
Clovis Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/23/2021
7:05 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
3:26 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 3/A
02/19/2021
3:17 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:30 PM
CITADEL ADVISORS LLC (Filed by)
Clovis Oncology (Subject)
Form SC 13G/A
02/16/2021
3:29 PM
Clovis Oncology (Subject)
Palo Alto Investors LP (Filed by)
Form SC 13G/A
02/16/2021
1:56 PM
Clovis Oncology (Subject)
WHITEBOX ADVISORS LLC (Filed by)
Form SC 13G/A
02/16/2021
12:45 PM
Capital World Investors (Filed by)
Clovis Oncology (Subject)
Form SC 13G/A
02/11/2021
1:38 PM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/10/2021
9:46 AM
Clovis Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/03/2021
3:15 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
3:15 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
3:15 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
3:15 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
3:15 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
9:01 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2021
7:07 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
3:52 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:51 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
7:05 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
11:15 PM
Clovis Oncology (Filer)
Form EFFECT
12/16/2020
3:15 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
3:20 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:52 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:50 PM
Clovis Oncology (Issuer)
Harding Thomas C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2020
8:46 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:45 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:42 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:42 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2020
5:07 AM
Clovis Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/27/2020
3:06 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
6:39 PM
ATWOOD BRIAN G (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:44 PM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
7:14 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:11 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
3:36 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:31 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
3:22 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
3:19 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
3:16 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
3:15 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:16 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
4:14 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
4:01 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
10:05 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/23/2020
4:16 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2020
4:15 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:31 PM
Clovis Oncology (Issuer)
GRAHAM GINGER L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:30 PM
Clovis Oncology (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:57 PM
Clovis Oncology (Issuer)
McKinley Edward J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:55 PM
Azelby Robert (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:54 PM
Clovis Oncology (Issuer)
KLINGENSTEIN PAUL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:53 PM
Clovis Oncology (Issuer)
SPICKSCHEN THORLEF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:51 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:50 PM
BLAIR JAMES C (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:49 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
3:36 PM
Clovis Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/28/2020
6:41 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:27 PM
Clovis Oncology (Filer)
Form 424B5
05/06/2020
2:12 PM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
3:38 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
2:25 PM
Clovis Oncology (Filer)
Form DEFA14A
04/24/2020
2:22 PM
Clovis Oncology (Filer)
Form DEF 14A
04/16/2020
4:30 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
4:22 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
3:44 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:42 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
4:28 PM
Clovis Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2020
4:22 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
6:27 PM
Clovis Oncology (Issuer)
MAHAFFY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:25 PM
Clovis Oncology (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
02/14/2020
11:00 AM
Clovis Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2020
9:54 AM
Clovis Oncology (Subject)
WHITEBOX ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2020
8:25 AM
Camber Capital Management LP (Filed by)
Clovis Oncology (Subject)
Form SC 13G/A
02/13/2020
3:20 PM
Clovis Oncology (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/13/2020
7:26 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2020
10:00 AM
Clovis Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.